Home Pilots Variantyx nabs $41.1M for tech-backed genomic analysis Pilots Variantyx nabs $41.1M for tech-backed genomic analysis By - February 14, 2022 82 0 Facebook Twitter Pinterest WhatsApp The company plans to use the funds to focus on the oncology space. RELATED ARTICLESMORE FROM AUTHOR Pilots Former Ripple exec Greg Kidd buys Know Labs with Bitcoin Pilots RadNet acquires See-Mode Technologies for access, revenue growth Pilots FDA launches AI tool for its employees LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Viome Life Sciences acquires Naring Health and its subsidiaries Pilots - November 2, 2023 0 Cognixion, Pupil Labs partner on eye-tracking interface Pilots - June 4, 2025 0 Roundup: Holmusk partners with American mental healthcare provider, MyHealthcare introduces latest HIMS and more... Pilots - February 11, 2022 0 AI-powered pathology startup PathAI teams up with GSK for drug discovery Pilots - April 5, 2022 0 Milvik launches mobile health app with wallet feature in Bangladesh Pilots - April 18, 2022 0 POPULAR CATEGORIESPilots2369Applications835Testing285Collaborations15GitHub3
